Company profile for UTC Therapeutics

NEW Drugs in Dev.: 2
PharmaCompass

Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

Update your Virtual Booth on PharmaCompass, ask us

About

UTC Therapeutics was founded in 2019 by Dr. Yangbing Zhao, Dr. Xiaojun Liu, and Dr. Daniel Song. The company traces its roots to the University of Pennsylvania (UPENN), where Dr. Zhao and Dr. Liu were key figures in T cell therapy research. Dr. Zhao notably contributed to the development of CAR-T therapies like Kymriah and Yescarta.

List your booth number for exhibitions, ask us

CONTACT DETAILS

Click the arrow to open the dropdown
Country
Country
Singapore
Address
Address
41 Science Park Road THE GEMINI #04-13/15
Telephone
Telephone
Linkedin
Linkedin
youtube
YouTube
Twitter
Twitter

Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

Events

Webinars & Exhibitions

Tides Asia

Tides Asia

Not Confirmed

envelop Contact Supplier

Tides Asia

Post an Enquiry

Meeting

ABOUT THIS PAGE

Ask Us for Pharmaceutical Supplier and Partner
Ask Us, Find A Supplier / Partner
No Commissions, No Strings Attached, Get Connected for FREE

What are you looking for?

How can we help you?

The request can't be empty

Please read our Privacy Policy carefully

You must agree to the privacy policy

The name can't be empty
The company can't be empty.
The email can't be empty Please enter a valid email.
The mobile can't be empty